I don't think anybody is talking about scrapping the tablet approval and going back to the drawing board with a liquid formulation, but if PAA did ALSO want to develop and seek approval for a liquid formula, in addition to the tablet formula, then possibly trials just concerning the liquid may be required.
I don't think anybody is talking about scrapping the tablet...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
-0.040(18.2%) |
Mkt cap ! $71.10M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 17.5¢ | $1.232M | 6.487M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 96617 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
18.0¢ |
Change
-0.040 ( 18.2 %) |
||||
| Open | High | Low | Volume | ||
| 20.5¢ | 20.5¢ | 17.5¢ | 3953302 | ||
| Last updated 15.56pm 09/05/2024 ? | |||||
| PAA (ASX) Chart |